Jump Financial LLC Buys 25,833 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Jump Financial LLC grew its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 391.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 32,429 shares of the medical instruments supplier's stock after purchasing an additional 25,833 shares during the period. Jump Financial LLC owned approximately 0.06% of Merit Medical Systems worth $3,137,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of Merit Medical Systems by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 6,648,659 shares of the medical instruments supplier's stock worth $643,058,000 after purchasing an additional 63,314 shares in the last quarter. FMR LLC increased its stake in Merit Medical Systems by 31.6% in the 4th quarter. FMR LLC now owns 2,076,439 shares of the medical instruments supplier's stock valued at $200,833,000 after buying an additional 499,193 shares during the period. Invesco Ltd. increased its stake in Merit Medical Systems by 8.3% in the 4th quarter. Invesco Ltd. now owns 1,535,468 shares of the medical instruments supplier's stock valued at $148,510,000 after buying an additional 118,142 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Merit Medical Systems by 2.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 748,561 shares of the medical instruments supplier's stock valued at $72,401,000 after buying an additional 21,221 shares during the period. Finally, Norges Bank acquired a new position in shares of Merit Medical Systems during the 4th quarter worth $66,638,000. 99.66% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Merit Medical Systems

In related news, insider Brian G. Lloyd sold 25,000 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $99.50, for a total value of $2,487,500.00. Following the completion of the transaction, the insider now owns 38,993 shares of the company's stock, valued at $3,879,803.50. This represents a 39.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Stephen C. Evans sold 5,000 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $105.31, for a total transaction of $526,550.00. Following the transaction, the director now owns 4,657 shares of the company's stock, valued at approximately $490,428.67. This represents a 51.78 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 109,132 shares of company stock valued at $11,139,521 in the last ninety days. Company insiders own 3.70% of the company's stock.

Wall Street Analysts Forecast Growth

MMSI has been the topic of several analyst reports. Barrington Research restated an "outperform" rating and set a $111.00 price target on shares of Merit Medical Systems in a research note on Friday, April 11th. Raymond James upped their price objective on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock an "outperform" rating in a report on Tuesday, December 31st. Piper Sandler reaffirmed an "overweight" rating and set a $116.00 price objective (up from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. JPMorgan Chase & Co. started coverage on shares of Merit Medical Systems in a report on Friday, March 28th. They set an "overweight" rating and a $120.00 price objective for the company. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $116.00 price objective on shares of Merit Medical Systems in a report on Wednesday, April 9th. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $114.33.

Merit Medical Systems Stock Performance

Merit Medical Systems stock traded up $2.55 during mid-day trading on Wednesday, reaching $94.00. The company had a trading volume of 299,477 shares, compared to its average volume of 486,629. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57. Merit Medical Systems, Inc. has a 52 week low of $72.81 and a 52 week high of $111.45. The company has a 50 day moving average of $99.45 and a 200-day moving average of $100.57. The firm has a market cap of $5.55 billion, a price-to-earnings ratio of 46.08, a PEG ratio of 2.34 and a beta of 0.85.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.